METAVERT Trademark

Trademark Overview

On Saturday, April 6, 2019, a trademark application was filed for METAVERT with the United States Patent and Trademark Office. The USPTO has given the METAVERT trademark a serial number of 88374297. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 31, 2022. This trademark is owned by Avenzoar, Inc.. The METAVERT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
metavert

General Information

Serial Number88374297
Word MarkMETAVERT
Filing DateSaturday, April 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2019

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAvenzoar, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90068
Party NameAvenzoar, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90068

Trademark Events

Event DateEvent Description
Monday, October 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2022SOU EXTENSION 5 GRANTED
Friday, March 4, 2022SOU EXTENSION 5 FILED
Tuesday, March 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 4, 2022TEAS EXTENSION RECEIVED
Tuesday, September 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 5, 2021SOU EXTENSION 4 GRANTED
Sunday, September 5, 2021SOU EXTENSION 4 FILED
Sunday, September 5, 2021TEAS EXTENSION RECEIVED
Friday, March 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 3, 2021SOU EXTENSION 3 GRANTED
Wednesday, March 3, 2021SOU EXTENSION 3 FILED
Wednesday, March 3, 2021TEAS EXTENSION RECEIVED
Saturday, August 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 13, 2020SOU EXTENSION 2 GRANTED
Thursday, August 13, 2020SOU EXTENSION 2 FILED
Thursday, August 13, 2020TEAS EXTENSION RECEIVED
Thursday, March 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 3, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 3, 2020SOU EXTENSION 1 FILED
Tuesday, March 3, 2020TEAS EXTENSION RECEIVED
Tuesday, September 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2019ASSIGNED TO EXAMINER
Thursday, April 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, April 10, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

metavert cancer treatment prevention products pharmaceutical